{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:15:28Z","timestamp":1772558128254,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dr William Peter Richards Bequest for Research in Veterinary Pathology 2015"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Canine prostatic adenocarcinoma is a rare but highly aggressive cancer that is typically diagnosed at an advanced stage, due to the lack of effective screening methods and poor recognition of early lesions. Cancer stem cells are known to drive tumour progression and treatment resistance in human prostate cancer, but their role in naturally occurring canine disease remains poorly defined. A deeper understanding of the biology of canine prostatic adenocarcinoma is therefore essential to improve prognosis and to develop relevant comparative models. We established and comprehensively characterised two novel canine prostatic adenocarcinoma cell lines, Kodiak and Bobby, with detailed comparison to their tumours of origin and, for Kodiak, xenografts generated in immunodeficient mice. Both lines displayed variable epithelial morphology influenced by culture conditions, and Kodiak xenografts recapitulated key histopathological patterns of the primary tumour. Expression of the luminal epithelial marker CK8\/18 and the basal marker CK14 was largely retained across tumour, cell line, and xenograft, whereas the basal markers CK5 and p63, and the urothelial marker UPIII, were diminished or lost during in vitro culture. Evaluation of cancer stem cell-associated markers showed consistent expression of CD44, Nanog, Oct3\/4, and Sox2 in the original tumours and cell lines, while CD133, Nestin, and Trop2 were present in the tumours but absent in vitro, indicating selective loss of specific stem-like populations. Media-dependent plasticity was evident in the Bobby line. These models retain key epithelial and stemness features and provide robust platforms for translational prostate cancer research in dogs and humans.<\/jats:p>","DOI":"10.3390\/ani16050732","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:51:29Z","timestamp":1772117489000},"page":"732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and Characterisation of Two Canine Prostate Cancer Cell Lines with Stem Cell Marker Expression"],"prefix":"10.3390","volume":"16","author":[{"given":"Michelle M.","family":"Story","sequence":"first","affiliation":[{"name":"School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4552-9736","authenticated-orcid":false,"given":"Brett W.","family":"Stringer","sequence":"additional","affiliation":[{"name":"Institute for Biomedicine and Glycomics, Griffith University, Nathan, QLD 4111, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-4220","authenticated-orcid":false,"given":"Rodney","family":"Straw","sequence":"additional","affiliation":[{"name":"Brisbane Veterinary Specialist Centre, Albany Creek, QLD 4035, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5791-6066","authenticated-orcid":false,"given":"Chiara","family":"Palmieri","sequence":"additional","affiliation":[{"name":"School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"ref_1","first-page":"647","article-title":"Prostatic carcinoma in dogs","volume":"5","author":"Hargis","year":"1983","journal-title":"Compend. Contin. Educ. Pract. Vet."},{"key":"ref_2","first-page":"284","article-title":"Prostatic disease in the dog","volume":"68","author":"Hornbuckle","year":"1978","journal-title":"Cornell Vet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0303-7207(02)00261-7","article-title":"Canine prostate carcinoma: Epidemiological evidence of an increased risk in castrated dogs","volume":"197","author":"Teske","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/vr.109.4.71","article-title":"Fifteen cases of prostatic carcinoma in the dog","volume":"109","author":"Weaver","year":"1981","journal-title":"Vet. Rec."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gibson, E.A., and Culp, W.T.N. (2024). Canine prostate cancer: Current treatments and the role of interventional oncology. Vet. Sci., 11.","DOI":"10.3390\/vetsci11040169"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nascente, E.d.P., Amorim, R.L., Fonseca-Alves, C.E., and de Moura, V.M.B.D. (2022). Comparative pathobiology of canine and human prostate cancer: State of the art and future directions. Cancers, 14.","DOI":"10.3390\/cancers14112727"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2442067","DOI":"10.1080\/07853890.2024.2442067","article-title":"Stemness regulation in prostate cancer: Prostate cancer stem cells and targeted therapy","volume":"57","author":"Liang","year":"2025","journal-title":"Ann. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1158\/0008-5472.CAN-06-4608","article-title":"Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo","volume":"67","author":"Gu","year":"2007","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.bjc.6604242","article-title":"CD44(+)CD24(\u2212) prostate cells are early cancer progenitor\/stem cells that provide a model for patients with poor prognosis","volume":"98","author":"Hurt","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1158\/0008-5472.CAN-07-5878","article-title":"PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","article-title":"Highly purified CD44(+) prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells","volume":"25","author":"Patrawala","year":"2006","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1158\/0008-5472.CAN-07-0490","article-title":"Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44(+) \u03b12\u03b21(+) cell population is enriched in tumor-initiating cells","volume":"67","author":"Patrawala","year":"2007","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.stem.2012.03.009","article-title":"The PSA(\u2212\/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration","volume":"10","author":"Qin","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"44492","DOI":"10.18632\/oncotarget.9876","article-title":"High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Jeter","year":"2011","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/stem.29","article-title":"Functional evidence that the self-renewal gene NANOG regulates human tumor development","volume":"27","author":"Jeter","year":"2009","journal-title":"Stem Cells"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.cellsig.2013.08.041","article-title":"SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells","volume":"25","author":"Rybak","year":"2013","journal-title":"Cell. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vaddi, P.K., Stamnes, M.A., Cao, H., and Chen, S. (2019). Elimination of SOX2\/OCT4-associated prostate cancer stem cells blocks tumor development and enhances therapeutic response. Cancers, 11.","DOI":"10.3390\/cancers11091331"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4314\/tjpr.v8i1.14706","article-title":"Oct-4 expression maintained stem cell properties in prostate cancer-derived CD133(+)MDR1(+) cells","volume":"8","author":"Rentala","year":"2009","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/stemcells.2004-0232","article-title":"Somatic stem cell marker prominin-1\/CD133 is expressed in embryonic stem cell-derived progenitors","volume":"23","author":"Kania","year":"2005","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1007\/s00018-004-4144-6","article-title":"Nestin expression\u2014A property of multi-lineage progenitor cells?","volume":"61","author":"Wiese","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4161\/cbt.6.5.3996","article-title":"Cancer stem-like cells in human prostate carcinoma DU145\u2014The seeds of the cell line?","volume":"6","author":"Wei","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"ref_24","first-page":"5421","article-title":"Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines","volume":"33","author":"Moulay","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biocel.2019.01.002","article-title":"Characterization of OCT3\/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer","volume":"108","author":"Costa","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rvsc.2015.09.004","article-title":"Proposal of a Gleason-like grading system of canine prostate carcinoma in veterinary pathology practice","volume":"103","author":"Palmieri","year":"2015","journal-title":"Res. Vet. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcpa.2019.07.005","article-title":"Histopathological terminology standards for the reporting of prostatic epithelial lesions in dogs","volume":"171","author":"Palmieri","year":"2019","journal-title":"J. Comp. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jhered\/esi085","article-title":"Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype","volume":"96","author":"Winkler","year":"2005","journal-title":"J. Hered."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/pros.22838","article-title":"Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivo","volume":"74","author":"Simmons","year":"2014","journal-title":"Prostate"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/pros.21341","article-title":"Development of a brain metastatic canine prostate cancer cell line","volume":"71","author":"Thudi","year":"2011","journal-title":"Prostate"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1097-0045(200101)46:1<2::AID-PROS1002>3.0.CO;2-5","article-title":"In vivo model mimicking natural history of dog prostate cancer using DPC-I, a new canine prostate carcinoma cell line","volume":"46","author":"Anidjar","year":"2001","journal-title":"Prostate"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pros.2990120204","article-title":"Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: Isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1","volume":"12","author":"Eaton","year":"1988","journal-title":"Prostate"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/pros.20408","article-title":"New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft","volume":"66","author":"LeRoy","year":"2006","journal-title":"Prostate"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/vco.12199","article-title":"The canine prostate cancer cell line CHP-1 shows overexpression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein","volume":"15","author":"Azakami","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fork, M.A.M., Murua Escobar, H., Soller, J.T., Sterenczak, K.A., Willenbrock, S., Winkler, S., Dorsch, M., Reimann-Berg, N., Hedrich, H.J., and Bullerdiek, J. (2008). Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-240"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sterenczak, K.A., Meier, M., Glage, S., Meyer, M., Willenbrock, S., Wefstaedt, P., Dorsch, M., Bullerdiek, J., Murua Escobar, H.M., and Hedrich, H. (2012). Longitudinal MRI contrast-enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258-based in vivo model of prostate cancer. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-284"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Packeiser, E.-M., Hewicker-Trautwein, M., Thiemeyer, H., Mohr, A., Junginger, J., Schille, J.T., Murua Escobar, H., and Nolte, I. (2020). Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230272"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/pros.23983","article-title":"Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis","volume":"80","author":"Elshafae","year":"2020","journal-title":"Prostate"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/vco.12879","article-title":"Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer","volume":"21","author":"Kobayashi","year":"2023","journal-title":"Vet. Comp. Oncol."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/5\/732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:50:39Z","timestamp":1772553039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/5\/732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ani16050732"],"URL":"https:\/\/doi.org\/10.3390\/ani16050732","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}